Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

China Biologic CFO Tristan Kuo Resigns

RELATED NEWS
Trade CBPO now with 

China Biologic Products, Inc. (CBPO) said Friday that its Chief Financial Officer, Y. Tristan Kuo, has resigned effective May 31.

Kuo is pursuing a new career opportunity and will serve as an independent consultant to the company for the next 12 months.

China Biologic said its Board of Directors has appointed Ming Yang, the company's Vice President - Finance & Compliance and Treasurer, as interim Chief Financial Officer, effective May 31.

Ming Yang joined the Company in March 2012 and has been serving as the company's Vice President - Finance & Compliance and Treasurer.

Click here to receive FREE breaking news email alerts for China Biologic Products Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Global consumer confidence increased in the second quarter to reach the highest levels since the first quarter in 2007 as job optimism improved, results of a survey by Nielsen showed Tuesday. The Nielsen Global Consumer Confidence Index rose a point from the previous quarter to 97 in the second quarter.... Texas Instruments Inc., the world's largest maker of analog chips, said Monday after the markets closed that its second quarter profit rose 3% from last year, as revenue increased 8%. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly revenue. At the same time, the company gave an upbeat outlook for the third quarter. After coming under pressure in early trading on Monday, stocks regained some ground over the course of the trading session but still closed modestly lower. The pullback on the day partly offset the strength that was seen last week.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.